Here are the latest quarterly results of DIVIS LABORATORIES. For more details, see the DIVIS LABORATORIES financial fact sheet and DIVIS LABORATORIES share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
3
Mar-24* |
3
Jun-24* |
3
Sep-24* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 17,080 | 19,510 | 17,780 | 19,090 | 18,550 | 23,030 | 21,180 | 23,380 | |
Other income | Rs m | 1,130 | 660 | 810 | 860 | 950 | 790 | 790 | 1,060 | |
Turnover | Rs m | 18,210 | 20,170 | 18,590 | 19,950 | 19,500 | 23,820 | 21,970 | 24,440 | |
Expenses | Rs m | 12,990 | 14,640 | 12,740 | 14,300 | 13,660 | 15,720 | 14,960 | 16,220 | |
Gross profit | Rs m | 4,090 | 4,870 | 5,040 | 4,790 | 4,890 | 7,310 | 6,220 | 7,160 | |
Depreciation | Rs m | 870 | 870 | 930 | 950 | 950 | 950 | 970 | 990 | |
Interest | Rs m | 0 | 0 | 0 | 10 | 0 | 20 | 0 | 10 | |
Profit before tax | Rs m | 4,350 | 4,660 | 4,920 | 4,690 | 4,890 | 7,130 | 6,040 | 7,220 | |
Tax | Rs m | 1,290 | 1,450 | 1,360 | 1,210 | 1,310 | 1,750 | 1,740 | 2,120 | |
Profit after tax | Rs m | 3,060 | 3,210 | 3,560 | 3,480 | 3,580 | 5,380 | 4,300 | 5,100 | |
Gross profit margin | % | 23.9 | 25.0 | 28.3 | 25.1 | 26.4 | 31.7 | 29.4 | 30.6 | |
Effective tax rate | % | 29.7 | 31.1 | 27.6 | 25.8 | 26.8 | 24.5 | 28.8 | 29.4 | |
Net profit margin | % | 17.9 | 16.5 | 20.0 | 18.2 | 19.3 | 23.4 | 20.3 | 21.8 | |
Diluted EPS | Rs | 11.5 | 12.1 | 13.4 | 13.1 | 13.5 | 20.3 | 16.2 | 19.2 | |
Diluted EPS (TTM) | Rs | 90.2 | 68.6 | 55.6 | 50.1 | 52.1 | 60.3 | 63.1 | 69.2 | |
Subscriber Feature |
After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.